Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia by Wang L, Giannoudis A, Lane S, Williamson P, Pirmohamed M, Clark R E in Clinical pharmacology and therapeutics (2008).

[PMID: 17568400] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.